Pediatric Paxil Third-Party Payor Settlement

Pediatric Paxil Third-Party Payor Settlement: "Pediatric Paxil Third-Party Payor Settlement"


http://www.pediatricpaxiltppsettlement.com/faq.htm

extract -

7. What does the settlement provide?




GSK has entered into a proposed settlement with the Plaintiffs and has agreed to pay $40 million to settle the claims set forth in Plaintiffs' lawsuits as follows:



After attorneys' fees and the costs of administering the settlement are deducted from the $40 million, the balance will be distributed to Class members who qualify and submit a claim as described below. The Class member's submission must certify, as provided in the claim form, that the member is seeking only the member's actual out-of-pocket and unreimbursed cost, based on the amount paid by the Class member, exclusive of any co-payments, deductibles, or other amounts not paid by the member to determine your actual costs for Paxil® prescribed for persons under the age of 18, between January 1, 1998 and December 31, 2004. If the records show a diagnosis of Major Depressive Disorder, the claim amount is calculated at 40% of the actual costs. Otherwise, the claim amount will be 15% of the actual costs.



If the total amount of qualified claims exceeds the available funds, claims will be reduced pro rata. If there is money left over after all claims are paid, the balance up to one million dollars will be donated to a charity involved with childrens' mental health issues. Any remainder of funds, after the charitable donation, shall be allocated to increase the amount payable to class members who have submitted qualifying claims, on a pro rata basis based upon the total pediatric Paxil expenditures during the class period that remain uncompensated after the initial claims process, without regard to diagnoses of the presence or absence of diagnostic information in any Class Member’s claims form.